(0.51%) 5 214.08 points
(0.85%) 39 388 points
(0.27%) 16 346 points
(0.39%) $79.57
(0.39%) $2.31
(0.55%) $2 353.10
(0.74%) $28.58
(0.85%) $993.00
(-0.30%) $0.927
(-0.37%) $10.85
(-0.24%) $0.798
(0.88%) $92.55
Quarter results tomorrow
(amc 2024-05-10)
Expected move: +/- 13.29%
-7.23% $ 1.540
Live Chart Being Loaded With Signals
Longeveron Inc., a clinical stage biotechnology company, develops cellular therapies for aging-related and life-threatening conditions. The company's lead investigational product is the LOMECEL-B, a cell-based therapy product that is derived from culture-expanded medicinal signaling cells that are sourced from bone marrow of young healthy adult donors...
Stats | |
---|---|
Dzisiejszy wolumen | 336 983 |
Średni wolumen | 2.19M |
Kapitalizacja rynkowa | 9.74M |
EPS | $0 ( 2024-02-27 ) |
Następna data zysków | ( $-2.01 ) 2024-05-10 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.150 |
ATR14 | $0.00700 (0.46%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-05-02 | Locklear Lisa | Sell | 410 | Class A Common Stock |
2024-05-02 | Agafonova Nataliya | Sell | 308 | Class A Common Stock |
2024-04-11 | Hare Joshua | Buy | 42 553 | Class A Common Stock |
2024-04-10 | Hare Joshua | Buy | 106 383 | Class A Common Stock |
2024-04-10 | Hare Joshua | Buy | 106 383 | Warrant (right to buy) |
INSIDER POWER |
---|
39.67 |
Last 100 transactions |
Buy: 1 179 927 | Sell: 677 468 |
Wolumen Korelacja
Longeveron Inc. Class A Korelacja
10 Najbardziej pozytywne korelacje | |
---|---|
EVOK | 0.972 |
VVOS | 0.97 |
UXIN | 0.968 |
CNSP | 0.963 |
KXIN | 0.962 |
AYLA | 0.961 |
RIDE | 0.961 |
AGRI | 0.957 |
ASLE | 0.957 |
BCAN | 0.955 |
10 Najbardziej negatywne korelacje | |
---|---|
BRIVU | -0.956 |
MSDA | -0.955 |
SGII | -0.947 |
RNLC | -0.947 |
KRUS | -0.944 |
STAY | -0.944 |
MASI | -0.941 |
TIOAU | -0.941 |
INBKZ | -0.94 |
ADTH | -0.939 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Longeveron Inc. Class A Korelacja - Waluta/Towar
Longeveron Inc. Class A Finanse
Annual | 2023 |
Przychody: | $709 000 |
Zysk brutto: | $-725 000 (-102.26 %) |
EPS: | $-9.85 |
FY | 2023 |
Przychody: | $709 000 |
Zysk brutto: | $-725 000 (-102.26 %) |
EPS: | $-9.85 |
FY | 2022 |
Przychody: | $1.22M |
Zysk brutto: | $497 000 (40.67 %) |
EPS: | $-9.36 |
FY | 2021 |
Przychody: | $1.31M |
Zysk brutto: | $590 000 (45.18 %) |
EPS: | $-0.897 |
Financial Reports:
No articles found.
Longeveron Inc. Class A
Longeveron Inc., a clinical stage biotechnology company, develops cellular therapies for aging-related and life-threatening conditions. The company's lead investigational product is the LOMECEL-B, a cell-based therapy product that is derived from culture-expanded medicinal signaling cells that are sourced from bone marrow of young healthy adult donors. It is conducting Phase 1 and 2 clinical trials in various indications, such as aging frailty, alzheimer's disease, metabolic syndrome, acute respiratory distress syndrome, and hypoplastic left heart syndrome. The company was incorporated in 2014 and is based in Miami, Florida.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej